ResMed RMD Sleep And Breathing Health — Operating Income (Loss)
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by ResMed in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: ResMed’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about ResMed's sleep and breathing health — operating income (loss).
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ResMed's sleep and breathing health — operating income (loss)?
- ResMed (RMD) reported sleep and breathing health — operating income (loss) of $575.41M in Q1 2026.
- How has ResMed's sleep and breathing health — operating income (loss) changed year-over-year?
- ResMed's sleep and breathing health — operating income (loss) increased by 16.3% year-over-year, from $494.8M to $575.41M.
- What is the long-term trend for ResMed's sleep and breathing health — operating income (loss)?
- Over 2 years (2023 to 2025), ResMed's sleep and breathing health — operating income (loss) has grown at a 16.5% compound annual growth rate (CAGR), from $1.45B to $1.96B.
- What does sleep and breathing health — operating income (loss) mean?
- Measures the profitability of the Sleep and Breathing Health segment after deducting direct and indirect operating expenses from segment revenue. It excludes corporate-level costs, interest, and taxes to isolate the performance of the core respiratory business. This is the primary metric for assessing the segment's operational health.